Interaction between host cells and microbes in chemotherapy-induced mucositis

Nutrients

Volumn 5, Issue 5, 2013, Pages 1488-1499

  Stringer, Andrea M ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Chemotherapy; Intestine; Microbiota; Mitogen activated protein kinase; Mucositis; Toll like receptors

Indexed keywords

AMSACRINE; ANTINEOPLASTIC AGENT; CYTARABINE; CYTOKINE; CYTOTOXIC AGENT; DAUNORUBICIN; ETOPOSIDE; FIRTECAN; FIRTECAN GLUCURONIDE; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IRINOTECAN; METHOTREXATE; MITOXANTRONE; MUCIN; REACTIVE OXYGEN METABOLITE;

ABDOMINAL PAIN; ACUTE GRANULOCYTIC LEUKEMIA; ADVERSE DRUG REACTION; BLOATING; BREAST CANCER; CANCER CHEMOTHERAPY; CHEMOTHERAPY INDUCED MUCOSITIS; COLORECTAL CANCER; CONSTIPATION; CYTOKINE PRODUCTION; DIARRHEA; DRUG MEGADOSE; DRUG METABOLISM; GASTROINTESTINAL SYMPTOM; HEARTBURN; HOST PATHOGEN INTERACTION; HUMAN; INFLAMMATION; INTESTINE FLORA; LIVER CANCER; MUCOSA INFLAMMATION; NAUSEA; NONHUMAN; PATHOPHYSIOLOGY; REVIEW; SINGLE DRUG DOSE; UPREGULATION;

EID: 84876949648     PISSN: 20726643     EISSN: None     Source Type: Journal    
DOI: 10.3390/nu5051488     Document Type: Review

References (60)

1. Keefe, D.M. Gastrointestinal mucositis: A new biological model. Support. Care Cancer 2004, 12, 6-9.
2. De Vita, V., Jr. Principals of Cancer Management: Chemotherapy. In Cancer: Principles and Practice of Oncology, 5th ed.; De Vita, V., Jr., Ed.; Lippincott-Raven: Philadelphia, PA, USA, 1997; pp. 333-347.
3. Cunningham, D.; Morgan, R.J.; Mills, P.R.; Nelson, L.M.; Toner, P.G.; Soukop, M.; McArdle, C.S.; Russell, R.I. Functional and structural changes of the human proximal small intestine after cytotoxic therapy. J. Clin. Pathol. 1985, 38, 265-270.
4. Keefe, D.M.; Gibson, R.J.; Hauer-Jensen, M. Gastrointestinal mucositis. Semin. Oncol. Nurs. 2004, 20, 38-47.
5. Duncan, M.; Grant, G. Oral and intestinal mucositis-causes and possible treatments. Aliment. Pharmacol. Ther. 2003, 18, 853-874.
6. Takasuna, K.; Hagiwara, T.; Hirohashi, M.; Kato, M.; Nomura, M.; Nagai, E.; Yokoi, T.; Kamataki, T. Involvement of beta-glucuronidase in intestinal microflora in the intestinal toxicity of the antitumor camptothecin derivative irinotecan hydrochloride (CPT-11) in rats. Cancer Res. 1996, 56, 3752-3757.
7. Ikuno, N.; Soda, H.; Watanabe, M.; Oka, M. Irinotecan (CPT-11) and characteristic mucosal changes in the mouse ileum and cecum. J. Natl. Cancer Inst. 1995, 87, 1876-1883.
8. Gibson, R.J.; Keefe, D.M.; Thompson, F.M.; Clarke, J.M.; Goland, G.J.; Cummins, A.G. Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats. Dig. Dis. Sci. 2002, 47, 2751-2757.
9. Gibson, R.J.; Keefe, D.M.; Clarke, J.M.; Regester, G.O.; Thompson, F.M.; Goland, G.J.; Edwards, B.G.; Cummins, A.G. The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer. Cancer Chemother. Pharmacol. 2002, 50, 53-58.
10. Keefe, D.M.; Brealey, J.; Goland, G.J.; Cummins, A.G. Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans. Gut 2000, 47, 632-637.
11. Sonis, S.T.; Elting, L.S.; Keefe, D.; Peterson, D.E.; Schubert, M.; Hauer-Jensen, M.; Bekele, B.N.; Raber-Durlacher, J.; Donnelly, J.P.; Rubenstein, E.B. Perspectives on cancer therapy-induced mucosal injury: Pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004, 100, 1995-2025.
12. Sonis, S.T. Pathobiology of mucositis. Semin. Oncol. Nurs. 2004, 20, 11-15.
13. Sonis, S.T. The pathobiology of mucositis. Nat. Rev. Cancer 2004, 4, 277-284.
14. Stringer, A.M.; Gibson, R.J.; Logan, R.M.; Bowen, J.M.; Yeoh, A.S.; Burns, J.; Keefe, D.M. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the da rat. Exp. Biol. Med. (Maywood) 2007, 232, 96-106.
15. Logan, R.M.; Stringer, A.M.; Bowen, J.M.; Yeoh, A.S.; Gibson, R.J.; Sonis, S.T.; Keefe, D.M. The role of pro-inflammatory cytokines in cancer treatment-induced alimentary tract mucositis: Pathobiology, animal models and cytotoxic drugs. Cancer Treat. Rev. 2007, 33, 448-460.
16. Gibson, R.J.; Bowen, J.M.; Inglis, M.R.; Cummins, A.G.; Keefe, D.M. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer. J. Gastroenterol. Hepatol. 2003, 18, 1095-1100.
17. Gibson, R.J.; Keefe, D.M. Cancer chemotherapy-induced diarrhoea and constipation: Mechanisms of damage and prevention strategies. Support. Care Cancer 2006, 14, 890-900.
18. Yeoh, A.S.; Bowen, J.M.; Gibson, R.J.; Keefe, D.M. Nuclear factor kappaB (NFkappaB) and cyclooxygenase-2 (cox-2) expression in the irradiated colorectum is associated with subsequent histopathological changes. Int. J. Radiat Oncol. Biol. Phys. 2005, 63, 1295-1303.
19. Logan, R.M.; Stringer, A.M.; Bowen, J.M.; Gibson, R.J.; Sonis, S.T.; Keefe, D.M. Serum levels of NFkappaB and pro-inflammatory cytokines following administration of mucotoxic drugs. Cancer Biol. Ther. 2008, 7, 1139-1145.
20. Logan, R.M.; Gibson, R.J.; Bowen, J.M.; Stringer, A.M.; Sonis, S.T.; Keefe, D.M. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: Implications for the pathobiology of mucositis. Cancer Chemother. Pharmacol. 2008, 62, 33-41.
21. Stringer, A.M.; Gibson, R.J.; Bowen, J.M.; Logan, R.M.; Ashton, K.; Yeoh, A.S.; Al-Dasooqi, N.; Keefe, D.M. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile. Int. J. Exp. Pathol. 2009, 90, 489-499.
22. Stringer, A.M.; Gibson, R.J.; Logan, R.M.; Bowen, J.M.; Yeoh, A.S.; Hamilton, J.; Keefe, D.M. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp. Biol. Med. (Maywood) 2009, 234, 430-441.
23. Stringer, A.M.; Gibson, R.J.; Logan, R.M.; Bowen, J.M.; Yeoh, A.S.; Laurence, J.; Keefe, D.M. Irinotecan-induced mucositis is associated with changes in intestinal mucins. Cancer Chemother. Pharmacol. 2009, 64, 123-132.
24. Sonis, S.T. A biological approach to mucositis. J. Support. Oncol. 2004, 2, 21-32; discussion 35-36.
25. Graham Espey, M. Role of oxygen gradients in shaping redox relationships between the human intestine and its microbiota. Free Radic. Biol. Med. 2012, doi:10.1016/j.freeradbiomed.2012.10.554.
26. Hartman, A.L.; Lough, D.M.; Barupal, D.K.; Fiehn, O.; Fishbein, T.; Zasloff, M.; Eisen, J.A. Human gut microbiome adopts an alternative state following small bowel transplantation. Proc. Natl. Acad. Sci. USA 2009, 106, 17187-17192.
27. Lambeth, J.D. Nox enzymes, ros, and chronic disease: An example of antagonistic pleiotropy. Free Radic. Biol. Med. 2007, 43, 332-347.
28. Lambeth, J.D.; Kawahara, T.; Diebold, B. Regulation of Nox and Duox enzymatic activity and expression. Free Radic. Biol. Med. 2007, 43, 319-331.
29. Van Vliet, M.J.; Tissing, W.J.; Dun, C.A.; Meessen, N.E.; Kamps, W.A.; de Bont, E.S.; Harmsen, H.J. Chemotherapy treatment in pediatric patients with acute myeloid leukemia receiving antimicrobial prophylaxis leads to a relative increase of colonization with potentially pathogenic bacteria in the gut. Clin. Infect. Dis. 2009, 49, 262-270.
30. Van Vliet, M.J.; Harmsen, H.J.; de Bont, E.S.; Tissing, W.J. The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. PLoS Pathog. 2010, 6, e1000879.
31. Rakoff-Nahoum, S.; Paglino, J.; Eslami-Varzaneh, F.; Edberg, S.; Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004, 118, 229-241.
32. Cario, E. Innate immune signalling at intestinal mucosal surfaces: A fine line between host protection and destruction. Curr. Opin. Gastroenterol. 2008, 24, 725-732.
33. Cario, E. Barrier-protective function of intestinal epithelial toll-like receptor 2. Mucosal Immunol. 2008, 1, S62-S66.
34. Hedl, M.; Li, J.; Cho, J.H.; Abraham, C. Chronic stimulation of Nod2 mediates tolerance to bacterial products. Proc. Natl. Acad. Sci. USA 2007, 104, 19440-19445.
35. Cario, E. Bacterial interactions with cells of the intestinal mucosa: Toll-like receptors and Nnod2. Gut 2005, 54, 1182-1193.
36. Kelly, D.; Campbell, J.I.; King, T.P.; Grant, G.; Jansson, E.A.; Coutts, A.G.; Pettersson, S.; Conway, S. Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA. Nat. Immunol. 2004, 5, 104-112.
37. Beg, A.A. Comppartmentalizing NF-kappaB in the gut. Nat. Immunol. 2004, 5, 14-16.
38. Ewaschuk, J.B.; Diaz, H.; Meddings, L.; Diederichs, B.; Dmytrash, A.; Backer, J.; Looijer-van Langen, M.; Madsen, K.L. Secreted bioactive factors from bifidobacterium infantis enhance epithelial cell barrier function. Am. J. Physiol. Gastrointest. Liver Physiol. 2008, 295, G1025-G1034.
39. Sokol, H.; Pigneur, B.; Watterlot, L.; Lakhdari, O.; Bermudez-Humaran, L.G.; Gratadoux, J.J.; Blugeon, S.; Bridonneau, C.; Furet, J.P.; Corthier, G.; et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of crohn disease patients. Proc. Natl. Acad. Sci. USA 2008, 105, 16731-16736.
40. Stringer, A.M.; Gibson, R.J.; Bowen, J.M.; Logan, R.M.; Yeoh, A.S.; Keefe, D.M. Chemotherapy-induced mucositis: The role of gastrointestinal microflora and mucins in the luminal environment. J. Support. Oncol. 2007, 5, 259-267.
41. Specian, R.D.; Oliver, M.G. Functional biology of intestinal goblet cells. Am. J. Physiol. 1991, 260, C183-C193.
42. Robbe, C.; Capon, C.; Coddeville, B.; Michalski, J.C. Structural diversity and specific distribution of O-glycans in normal human mucins along the intestinal tract. Biochem. J. 2004, 384, 307-316.
43. Deplancke, B.; Gaskins, H.R. Microbial modulation of innate defense: Goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 2001, 73, 1131S-1141S.
44. Mack, D.R.; Michail, S.; Wei, S.; McDougall, L.; Hollingsworth, M.A. Probiotics inhibit enteropathogenic e. Coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 1999, 276, G941-G950.
45. Enss, M.L.; Cornberg, M.; Wagner, S.; Gebert, A.; Henrichs, M.; Eisenblatter, R.; Beil, W.; Kownatzki, R.; Hedrich, H.J. Proinflammatory cytokines trigger MUC gene expression and mucin release in the intestinal cancer cell line LS180. Inflamm. Res. 2000, 49, 162-169.
46. Jarry, A.; Vallette, G.; Branka, J.E.; Laboisse, C. Direct secretory effect of interleukin-1 via type I receptors in human colonic mucous epithelial cells (HT29-C1.16E). Gut 1996, 38, 240-242.
47. Stringer, A.M.; Gibson, R.J.; Logan, R.M.; Bowen, J.M.; Yeoh, A.S.; Keefe, D.M. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats. Cancer Biol. Ther. 2008, 7, 1919-1925.
48. Stringer, A.M.; Gibson, R.J.; Bowen, J.M.; Keefe, D.M. Chemotherapy-induced modifications to gastrointestinal microflora: Evidence and implications of change. Curr. Drug Metab. 2009, 10, 79-83.
49. Lin, X.B.; Dieleman, L.A.; Ketabi, A.; Bibova, I.; Sawyer, M.B.; Xue, H.; Field, C.J.; Baracos, V.E.; Ganzle, M.G. Irinotecan (CPT-11) chemotherapy alters intestinal microbiota in tumour bearing rats. PLoS One 2012, 7, e39764.
50. Bowen, J.M.; Gibson, R.J.; Tsykin, A.; Stringer, A.M.; Logan, R.M.; Keefe, D.M. Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy. Int. J. Cancer 2007, 121, 1847-1856.
51. Bowen, J.M.; Gibson, R.J.; Cummins, A.G.; Tyskin, A.; Keefe, D.M. Irinotecan changes gene expression in the small intestine of the rat with breast cancer. Cancer Chemother. Pharmacol. 2007, 59, 337-348.
52. Von Bultzingslowen, I.; Adlerberth, I.; Wold, A.E.; Dahlen, G.; Jontell, M. Oral and intestinal microflora in 5-fluorouracil treated rats, translocation to cervical and mesenteric lymph nodes and effects of probiotic bacteria. Oral Microbiol. Immunol. 2003, 18, 278-284.
53. Zwielehner, J.; Lassl, C.; Hippe, B.; Pointner, A.; Switzeny, O.J.; Remely, M.; Kitzweger, E.; Ruckser, R.; Haslberger, A.G. Changes in human fecal microbiota due to chemotherapy analyzed by TaqMan-PCR, 454 sequencing and PCR-DGGE fingerprinting. PLoS One 2011, 6, e28654.
54. De Koning, B.A.; Sluis, M.; Lindenbergh-Kortleve, D.J.; Velcich, A.; Pieters, R.; Buller, H.A.; Einerhand, A.W.; Renes, I.B. Methotrexate-induced mucositis in mucin 2-deficient mice. J. Cell. Physiol. 2007, 210, 144-152.
55. Saegusa, Y.; Ichikawa, T.; Iwai, T.; Goso, Y.; Okayasu, I.; Ikezawa, T.; Shikama, N.; Saigenji, K.; Ishihara, K. Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand. J. Gastroenterol. 2008, 43, 59-65.
56. Verburg, M.; Renes, I.B.; Meijer, H.P.; Taminiau, J.A.; Buller, H.A.; Einerhand, A.W.; Dekker, J. Selective sparing of goblet cells and paneth cells in the intestine of methotrexate-treated rats. Am. J. Physiol. Gastrointest. Liver Physiol. 2000, 279, G1037-G1047.
57. Logan, R.M.; Stringer, A.M.; Bowen, J.M.; Gibson, R.J.; Sonis, S.T.; Keefe, D.M. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother. Pharmacol. 2009, 63, 239-251.
58. Melo, M.L.; Brito, G.A.; Soares, R.C.; Carvalho, S.B.; Silva, J.V.; Soares, P.M.; Vale, M.L.; Souza, M.H.; Cunha, F.Q.; Ribeiro, R.A. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: Effect of pentoxifylline and thalidomide. Cancer Chemother. Pharmacol. 2008, 61, 775-784.
59. Curra, M.; Martins, M.A.; Lauxen, I.S.; Pellicioli, A.C.; Sant'ana Filho, M.; Pavesi, V.C.; Carrard, V.C.; Martins, M.D. Effect of topical chamomile on immunohistochemical levels of IL-1beta and TNF-alpha in 5-fluorouracil-induced oral mucositis in hamsters. Cancer Chemother. Pharmacol. 2013, 71, 293-299.
60. Soares, P.M.; Mota, J.M.; Souza, E.P.; Justino, P.F.; Franco, A.X.; Cunha, F.Q.; Ribeiro, R.A.; Souza, M.H. Inflammatory intestinal damage induced by 5-fluorouracil requires IL-4. Cytokine 2013, 61, 46-49.